RIBOMAP
LIVE

Serial Number

99228511

Owner

Stellaromics, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Jun 11, 2025

Add to watchlist:

No watchlists yet
View on USPTO

RIBOMAP Trademark

Serial Number: 99228511

RIBOMAP is a trademark filed by Stellaromics, Inc. on June 11, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Stellaromics, Inc. (7 trademarks)

321 Harrison Avenue
Boston, MA 02118

Entity Type: 03

Trademark Details

Filing Date

June 11, 2025

Registration Date

Not Registered

Published for Opposition

March 10, 2026

Goods & Services

Scientific research and analysis, namely, in situ multi-omic research and analysis, spatial transcriptomics research and analysis, and protein research and analysis; Clinical research in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis; Analysis, evaluation, and development of therapeutics medicines for research, scientific, and clinical use

Medical diagnostic testing and reporting services in the fields of in situ multi-omic analysis, spatial transcriptomics, and protein analysis

Medical instruments, namely, instruments for in situ multi-omic analysis, for diagnostic purposes

Scientific instruments, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of biomolecules and spatial interactions between biomolecules and cells in situ; Medical laboratory research instruments for in situ multi-omic analysis, spatial transcriptomics, and protein analysis

Chemical reagents for scientific and research use, namely, multi-omic reagents for research, scientific, and clinical laboratory use; Biomarker reagents for research, scientific, and clinical laboratory use

Clinical medical reagents, namely, multi-omic reagents for medical use; Diagnostic biomarker reagents for clinical medical purposes

Filing History

NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 5, 2026 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 10, 2026 NPUB
PUBLISHED FOR OPPOSITION
Mar 10, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 4, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 12, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 11, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 11, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 11, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 29, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 29, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 3, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 30, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 17, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Jun 11, 2025 MAFR
NEW APPLICATION ENTERED
Jun 11, 2025 NWAP